Trending...
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 134
- The $112M Marketing Lesson Joe Whyte Learned: Why 'More Traffic' Is the Biggest Lie in Digital Marketing
- Daniel Kaufman Expands Kaufman & Company Real Estate Platform With New Acquisitions, AI-Driven Industrial Development and Nationwide Growth Initiative
Media Contact: LARA Communications 517-335-LARA (5272)
Email: mediainfo@michigan.gov
November 22, 2019 – The Marijuana Regulatory Agency (MRA) promulgated emergency rules today for marijuana products intended for inhalation to address the public health crisis of e-cigarette, or vaping, product use-associated lung injury (EVALI) to ensure the public health, safety, and welfare of adult-use and medical marijuana consumers.
"It is absolutely vital that patients and consumers know, with certainty, the ingredients in the products that they are using," said Lt. Gov. Garlin Gilchrist. "These rules require stringent testing and will continue to prioritize the health and safety of Michiganders."
"As always, our primary goal is to protect the public's health," said MRA Executive Director Andrew Brisbo. "The collaboration with our public health partners over the last several months has resulted in the issuance of these rules which will increase consumer confidence in the regulated supply of marijuana products intended for inhalation."
The MRA is now requiring that all inactive ingredients added to marijuana products be clearly listed on the product label. Additionally, marijuana licensees are prohibited from using inactive ingredients that are not approved by the Food and Drug Administration (FDA) for inhalation. All ingredients added to marijuana products intended for inhalation must be FDA-approved for inhalation and cannot exceed the maximum concentration listed in the FDA Inactive Ingredient database.
More on Michimich.com
The MRA will inspect processing facilities twice a month to ensure compliance with these manufacturing standards. Also, the MRA will require licensed safety compliance facilities to test for vitamin E acetate.
Effective immediately, licensees may not sell a marijuana product which is intended for inhalation (vaping) unless one of the following conditions is met:
"Prohibiting additives that could cause harm to human health is a step forward in efforts to protect the public during this outbreak of lung injury cases," said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health for the Michigan Department of Health and Human Services.
The emergency rules may be read here and here.
Background on the EVALI Public Health Crisis
The Michigan Department of Health and Human Services (MDHHS) has identified 55 EVALI cases, with one patient requiring a double lung transplant. Approximately 88 percent of EVALI patients reported using a product containing tetrahydrocannabinol (THC). As part of their investigation, MDHHS sent samples from five Michigan patients to the Food and Drug Administration (FDA) for testing. The FDA found that one patient's products contained THC and vitamin E acetate; and one product – a THC cartridge called "Dank Vape Birthday Cake" – contained 23 percent vitamin E acetate. The age range of the patients is 15 to 67 years old and most have been hospitalized for severe respiratory illness; many of these persons are likely to suffer permanent effects from these illnesses.
More on Michimich.com
The Centers for Disease Control and Prevention (CDC) has confirmed 42 deaths and over 2,100 cases of EVALI across 49 states, the District of Columbia and two U.S. territories. All cases have a history of vaping products containing THC, nicotine, or a combination of THC and nicotine. The CDC announced the results of recent testing performed on bronchoalveolar lavage (BAL) fluid samples from 29 EVALI patients in 10 states, including Michigan. Vitamin E acetate was identified in 100 percent of the BAL samples tested. THC was identified in 82 percent of the samples. This is the first time that a potential toxin has been detected in biologic samples from patients with EVALI. While vitamin E acetate does not usually cause harm when ingested as a dietary supplement or applied to the skin, ongoing research suggests that inhalation of vitamin E acetate may interfere with normal lung function.
Because the number of EVALI cases continues to rise, these emergency rules are necessary to regulate the presence and addition of inactive ingredients to marijuana products intended for inhalation and require testing for those inactive ingredients. Preservation of public health requires promulgation of these emergency rules; without immediate regulation of inactive ingredients in marijuana products, the public health risk of EVALI will continue unmitigated. Preservation of public welfare also requires that consumers use the regulated marijuana market rather than the illicit market; the regulated market is tested for the presence of harmful contaminants and generates tax revenue for the people of Michigan.
Ensuring that regulated marijuana products intended for inhalation are reasonably free from contaminants will promote consumer confidence in the regulated market, and therefore will promote the preservation of public health, safety, and welfare.
Email: mediainfo@michigan.gov
November 22, 2019 – The Marijuana Regulatory Agency (MRA) promulgated emergency rules today for marijuana products intended for inhalation to address the public health crisis of e-cigarette, or vaping, product use-associated lung injury (EVALI) to ensure the public health, safety, and welfare of adult-use and medical marijuana consumers.
"It is absolutely vital that patients and consumers know, with certainty, the ingredients in the products that they are using," said Lt. Gov. Garlin Gilchrist. "These rules require stringent testing and will continue to prioritize the health and safety of Michiganders."
"As always, our primary goal is to protect the public's health," said MRA Executive Director Andrew Brisbo. "The collaboration with our public health partners over the last several months has resulted in the issuance of these rules which will increase consumer confidence in the regulated supply of marijuana products intended for inhalation."
The MRA is now requiring that all inactive ingredients added to marijuana products be clearly listed on the product label. Additionally, marijuana licensees are prohibited from using inactive ingredients that are not approved by the Food and Drug Administration (FDA) for inhalation. All ingredients added to marijuana products intended for inhalation must be FDA-approved for inhalation and cannot exceed the maximum concentration listed in the FDA Inactive Ingredient database.
More on Michimich.com
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
- Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
- UK Financial Ltd Confirms CATEX Exchange Integration of SMPRA and LTNS 1 Ahead of Compliance-Based Trading Activation
- Ashikaga Flower Park's "Great Wisteria Festival 2026"
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
The MRA will inspect processing facilities twice a month to ensure compliance with these manufacturing standards. Also, the MRA will require licensed safety compliance facilities to test for vitamin E acetate.
Effective immediately, licensees may not sell a marijuana product which is intended for inhalation (vaping) unless one of the following conditions is met:
- the product has received a passing test result under these rules
- the product was produced by a licensed processor after the effective date of these rules and in compliance with all rules promulgated by the MRA
"Prohibiting additives that could cause harm to human health is a step forward in efforts to protect the public during this outbreak of lung injury cases," said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health for the Michigan Department of Health and Human Services.
The emergency rules may be read here and here.
Background on the EVALI Public Health Crisis
The Michigan Department of Health and Human Services (MDHHS) has identified 55 EVALI cases, with one patient requiring a double lung transplant. Approximately 88 percent of EVALI patients reported using a product containing tetrahydrocannabinol (THC). As part of their investigation, MDHHS sent samples from five Michigan patients to the Food and Drug Administration (FDA) for testing. The FDA found that one patient's products contained THC and vitamin E acetate; and one product – a THC cartridge called "Dank Vape Birthday Cake" – contained 23 percent vitamin E acetate. The age range of the patients is 15 to 67 years old and most have been hospitalized for severe respiratory illness; many of these persons are likely to suffer permanent effects from these illnesses.
More on Michimich.com
- Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
- New Research Identifies "The Busy Effect": 89% of Americans Want a Laid-Back Vacation — Only 15% Actually Achieve It
- Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
- Best Spiritual Healing, Meditation & Retreats in Sedona — Rise Meditation Helps You Find and Book Transformational Experiences
- $16 Billion Market by 2034 in Underwater Drones Presents Huge Opportunity for AI-Powered Autonomous Vehicle Serving Defense & Commercial Customers
The Centers for Disease Control and Prevention (CDC) has confirmed 42 deaths and over 2,100 cases of EVALI across 49 states, the District of Columbia and two U.S. territories. All cases have a history of vaping products containing THC, nicotine, or a combination of THC and nicotine. The CDC announced the results of recent testing performed on bronchoalveolar lavage (BAL) fluid samples from 29 EVALI patients in 10 states, including Michigan. Vitamin E acetate was identified in 100 percent of the BAL samples tested. THC was identified in 82 percent of the samples. This is the first time that a potential toxin has been detected in biologic samples from patients with EVALI. While vitamin E acetate does not usually cause harm when ingested as a dietary supplement or applied to the skin, ongoing research suggests that inhalation of vitamin E acetate may interfere with normal lung function.
Because the number of EVALI cases continues to rise, these emergency rules are necessary to regulate the presence and addition of inactive ingredients to marijuana products intended for inhalation and require testing for those inactive ingredients. Preservation of public health requires promulgation of these emergency rules; without immediate regulation of inactive ingredients in marijuana products, the public health risk of EVALI will continue unmitigated. Preservation of public welfare also requires that consumers use the regulated marijuana market rather than the illicit market; the regulated market is tested for the presence of harmful contaminants and generates tax revenue for the people of Michigan.
Ensuring that regulated marijuana products intended for inhalation are reasonably free from contaminants will promote consumer confidence in the regulated market, and therefore will promote the preservation of public health, safety, and welfare.
0 Comments
Latest on Michimich.com
- L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
- FinIQ Edu Launches High-Impact Workshop Vertical to Close the Workplace Benefits Gap—Drives 82% Surge in 401(k) Participation Intent
- HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
- J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
- Wayne Rubber Opens First Manufacturing Facility in Wixom, Michigan
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
- Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
- IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
- AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
- Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)
- Mom Creators Coalition Launches with WaterWipes® as Official Founding Sponsor
- PandaGuarantee Launches Rent Guarantor Service in New York City
- The $112M Marketing Lesson Joe Whyte Learned: Why 'More Traffic' Is the Biggest Lie in Digital Marketing
- Daniel Kaufman Expands Kaufman & Company Real Estate Platform With New Acquisitions, AI-Driven Industrial Development and Nationwide Growth Initiative
- Cozy Manufactured Home Community Announces Largest Spring Sale in Its History: Unprecedented Savings
- Outdoor Tech Lab Launches Backcountry Pulse With Spring 2026 Camping Safety Field Report
- purelyIV Launches Lab Testing Services in Metro Detroit
- On the 296th Anniversary of the Ceremony That Made His Ancestor Emperor, a Cherokee Descendant Publishes the Novel That Restores Him
- NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
- DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model